Results 31 to 40 of about 15,682 (220)
Key molecules of Mucorales for COVID-19-associated mucormycosis: a narrative review
Journal of Bio-X Research, 2022 Mucormycosis is a lethal human disease caused by fungi of the order Mucorales. Mucormycosis is caused by fungi mainly belonging to the genera Mucor, Rhizopus, and Lichtheimia, all of which belong to the order Mucorales.
Priyanka Baberwal +3 more
doaj +1 more source
Effectiveness of COVID-19 Vaccination against COVID -associated Mucormycosis [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Coronavirus Disease-2019 (COVID-19) infections may be associated with a wide range of opportunistic bacterial and fungal co-infections. Both Aspergillus and Candida have been reported as the main fungal pathogens for co-infection in people ...
Rohit Mahla, Saurabh Shrivastava
doaj +1 more source
Mucormycosis following COVID19: clinical case and literature review [PDF]
Клиническая микробиология и антимикробная химиотерапия, 2021 Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical form and background disease, varies from 30% to 100%.
Khostelidi S.N. +7 more
doaj +1 more source
COVID19 associated mucormycosis: A review
Journal of Family Medicine and Primary Care, 2022 Mucormycosis, a rare fungal disease has emerged as a new epidemic in India, during the CoronaVirus Disease 2019 (COVID-19) pandemic. Mucormycosis is caused by the mucormycetes group of molds. Immunocompromised states such as diabetes, chronic steroid use,
Priyadharsini R Palanisamy +1 more
doaj +1 more source
, 2023 Mucormycosis is an angioinvasive opportunistic fungal infection, but these have become emerging pathogens, especially in conditions with underlying predisposing risk factors in a favourable setting.
V. Dillirani +3 more
core +1 more source
Cutaneous Mucormycosis Co-infection in a Patient with COVID-19 [PDF]
, 2022 Mucormycosis is a life-threatening fungal infection usually seen in patients who are immunocompromised; however, to date, it has been rarely described in patients with COVID-19, although more recently, reports from India have described an increased ...
Peter Goldberg +3 more
core +1 more source
A short review on black fungal mucormycosis accompanied by Post-SARS-CoV-2
Journal of the Scientific Society, 2023 Many people who have recovered from coronavirus disease 2019 (COVID-19) have recently been diagnosed with black fungus – or mucormycosis – disease. Rhino-orbital mucormycosis is becoming more common in people with COVID-19, particularly in India.
Abhishek Lachyan +3 more
doaj +1 more source
Mucormycosis in a Patient with Uncontrolled Diabetes Mellitus
, 2022 Mucormycosis; is a rapidly progressive fungal infection due to filamentous fungi of the mucoraceae family. In this case report, we aimed to present the diagnosis and treatment modalities of a patient who developed rhinoorbital mucormycosis. A 54-year-old
Gökhan Günbay +9 more
core +1 more source
Journal of Fungi, 2018 Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in addition to amphotericin B products, to our armamentarium against mucormycosis, many uncertainties remain for the management of this uncommon opportunistic infection, as there are no data from prospective randomized clinical trials to guide therapy.
Nikolaos V. Sipsas +3 more
openaire +4 more sources
COVID-19–associated central nervous system mucormycosis
Apollo Medicine, 2021 Mucormycosis is a life-threatening infection caused by fungi of the order Mucorales. Central nervous system (CNS) mucormycosis is usually an extension of the infection from the sinuses to the eyes and brain.
Anjali Mishra +2 more
doaj +1 more source